Because of the rapid and serious nature of acute cardiovascular disease (CVD) especially ST segment elevation myocardial infarction (STEMI), a leading cause of death worldwide, prompt diagnosis and treatment is of crucial importance to reduce both mortality and morbidity. During a pandemic such as coronavirus disease-2019 (COVID-19), it is critical to balance cardiovascular emergencies with infectious risk. In this work, we recommend using wearable device based mobile health (mHealth) as an early screening and real-time monitoring tool to address this balance and facilitate remote monitoring to tackle this unprecedented challenge. This recommendation may help to improve the efficiency and effectiveness of acute CVD patient management while reducing infection risk.

中文翻译：

---

建议在 COVID-19 大流行期间使用基于可穿戴设备的移动医疗对急性心血管疾病患者进行闭环管理

由于急性心血管疾病（CVD）尤其是 ST 段抬高型心肌梗死（STEMI）的快速且严重的性质，是全世界死亡的主要原因，因此及时诊断和治疗对于降低死亡率和发病率至关重要。在 2019 年冠状病毒病 (COVID-19) 等大流行期间，平衡心血管紧急情况与感染风险至关重要。在这项工作中，我们建议使用基于可穿戴设备的移动健康（mHealth）作为早期筛查和实时监测工具，以解决这种平衡并促进远程监测，以应对这一前所未有的挑战。该建议可能有助于提高急性 CVD 患者管理的效率和有效性，同时降低感染风险。